Skip to main content
Clinical Trials/CTRI/2023/02/049552
CTRI/2023/02/049552Not yet recruitingNot Applicable

Clinical significance of serum uric acid in adult patients with sepsis

Kasturba Medical College1 site in 1 country226 target enrollmentStarted: February 15, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
226
Locations
1
Primary Endpoint
Outcome assessed interms of mean hospital stay, acute kidney injury, need for dialysis, days of mechanical ventilation, patient condition at discharge(survivors/non survivors) in relation to serum uric acid between two cohorts

Study Overview

Brief Summary

Our study is a prospective, cohort, observational study conducted at Kasturba Medical College, Manipal, India. Adult patients with clinical suspicion of sepsis admitted to Medical Intensive Care Units will be included in the study.

The data of the patients including demographic characteristics, comorbidity, source of infection, APACHE II Score and SOFA Score, mechanical ventilation, and length of ICU stay will be recorded in a data proforma. The presence of sepsis will be made at the time of admission among hospitalized patients based on SOFA score of ≥ 2. Vital signs, scoring system and laboratory parameters will be recorded at admission to the ICU. Laboratory data at admission including complete blood count, liver function and renal function tests, serum electrolytes, uric acid, lactate and arterial blood gas analysis will be collected and documented.

The disease severity will be evaluated with the Sequential Organ Failure Assessment (SOFA) Score and Acute Physiology and Chronic Health Evaluation (APACHE) II Score.

As this study is purely observational, patient management and antimicrobial therapy will be chosen by patient’s physician without any intervention from study investigators.

Outcome will be assessed in terms of mean hospital stay, acute kidney injury, need for dialysis, mechanical ventilation and patient condition at the time of discharge (survivors/non survivors) in relation to serum uric acid levels.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18.00 Year(s) to 99.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •Patients aged 18 years or older admitted to medical intensive care units with clinical suspicion of sepsis based on the Sepsis-3 definition which includes sequential organ failure assessment (SOFA) score of ≥ 2 will be included in the study.

Exclusion Criteria

  • •Patients with chronic kidney disease, gout and those on diuretics will be excluded from the study​
  • •Patients on treatment for hyperuricemia​
  • •Patients with malignancies will also be excluded.

Outcomes

Primary Outcomes

Outcome assessed interms of mean hospital stay, acute kidney injury, need for dialysis, days of mechanical ventilation, patient condition at discharge(survivors/non survivors) in relation to serum uric acid between two cohorts

Time Frame: At discharge/ death

Secondary Outcomes

  • nill(nill)

Investigators

Sponsor Class
Private medical college

Study Sites (1)

Loading locations...

Similar Trials